Advanced, Secure, and Reliable Biosafety Level 3 Solutions
Our established and compliant BSL 3 facilities offer comprehensive preclinical and clinical testing capabilities for select agents and emerging infectious diseases. We rigorously evaluate vaccine and therapeutic candidates, ensuring adherence to the highest safety standards and regulatory compliance throughout your development pipeline.
What Sets Us Apart:
- Select Agent (Tier One) Handling and Testing
- Large Animal Study Capabilities
- GLP-Compliant Facility
- High-Throughput Screening (HTS) in Multiple Formats
- Clinical Trial Sample Analysis within BSL 3
- Comprehensive Bioanalytical (BioA) Capabilities
Established BSL 3 Facility
Our upgraded BSL 3 laboratory is designed for high containment and advanced testing capabilities, supporting cutting-edge research and robust safety standards.
Infectious Disease Research (IDR)
Our current IDR work includes developing animal models and assays for established and emerging pathogens, contributing to global preparedness and response to infectious disease threats.
High-Throughput Screening (HTS)
We support high-throughput screening in various formats and maintain an extensive library of validated antiviral assays, enabling efficient and reliable candidate evaluation.
Clinical Trial Sample Analysis
We perform rigorous clinical trial sample analyses against pathogens within the BSL 3 environment, ensuring accurate data generation and compliance with stringent biosafety protocols.
Bioanalytical (BioA) Services
Our bioanalytical capabilities include an extensive range of assays designed for BSL 3 applications, providing comprehensive analytical support for both preclinical and clinical samples.
Our Experts
Jennifer Pickens, Ph.D.
Miranda Nebane
Sanjay Sarkar
Ready to Advance Your Research?
Contact our experts today and explore how Southern Research can elevate your project.